InvestorsHub Logo
Followers 36
Posts 1470
Boards Moderated 0
Alias Born 11/12/2013

Re: CallMeCrazy post# 346385

Wednesday, 02/17/2021 10:04:25 AM

Wednesday, February 17, 2021 10:04:25 AM

Post# of 403583
Way to go Leo. Let 'em know as little as possible, as late as possible.

Innovation Pharmaceuticals Inc. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q (the “Quarterly Report”) for the period ended December 31, 2020 (the “Reporting Period”) by the February 16, 2021 filing due date applicable to non-accelerated filers due to a delay experienced by the Registrant in preparing disclosure relating to recent developments regarding clinical trials for the Registrant’s lead drug compound, and in particular, developments on or around the filing due date relating to clinical trials in the United States and Russia. The Registrant anticipates that it will file the Quarterly Report no later than the fifth calendar day following the prescribed filing due date. Emphasis added


http://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-qb-IPIX/stock-news/84360248/notification-that-quarterly-report-will-be-submitt

I suppose there will be those who will still wonder when Leo is going to announce the start of the B-COVID trial (U.S.).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News